CD24 Offers a Therapeutic Target for Control of Bladder Cancer Metastasis Based on a Requirement for Lung Colonization
2011 · Cancer Research · 118 citations
https://doi.org/10.1158/0008-5472.can-11-0519
S
Shibu Thomas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
160
Papers
2.4K
Citations
27
h-index
43
i10-index
Shibu Thomas is an academic researcher from Janssen (United States). The author has contributed to research in topics: Prostate Cancer Treatment and Research & Bladder and Urothelial Cancer Treatments & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 27, co-authored 136 publications.
Papers by this author
worksCD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated
2012 · Proceedings of the National Academy of Sciences · 95 citations
https://doi.org/10.1073/pnas.1113960109
Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTAN
2021 · European Urology · 45 citations
https://doi.org/10.1016/j.eururo.2021.11.020
Cadherin Switching and Activation of β-Catenin Signaling Underlie Proinvasive Actions of Calcitonin-Calcitonin Receptor Axis in Prostate Cancer
2008 · Journal of Biological Chemistry · 41 citations
https://doi.org/10.1074/jbc.m807823200
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real‐World Setting
2025 · Cancer Medicine · 1 citations
https://doi.org/10.1002/cam4.70546
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat